Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mørk N[au]:

Search results

Items: 1 to 50 of 58

1.

[Congenital uterine anomalies and their association with fertility and pregnancy outcomes].

Mørk N, Lauszus FF, Agha Krogh RH.

Ugeskr Laeger. 2018 Oct 1;180(40). pii: V02180149. Danish.

PMID:
30274578
2.

[Caesarean delivery in a woman with a unicorn uterus and foetal breech presentation].

Mørk N, Lauszus FF, Agha Krogh RH.

Ugeskr Laeger. 2018 Jul 2;180(27). pii: V01180065. Danish.

PMID:
29984693
3.

TNF-α Inhibitors and Efalizumab for the Treatment of Skin Diseases [Internet].

Sæterdal I, Mørk NJ, Dalaker M, Langeland T, Tolaas E, Movik E, Odgaard-Jensen J, Lyngstadaas A, Klemp Gjertsen M.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 May.

4.

Frequently used bioinformatics tools overestimate the damaging effect of allelic variants.

Andersen LL, Terczyńska-Dyla E, Mørk N, Scavenius C, Enghild JJ, Höning K, Hornung V, Christiansen M, Mogensen TH, Hartmann R.

Genes Immun. 2019 Jan;20(1):10-22. doi: 10.1038/s41435-017-0002-z. Epub 2017 Dec 4.

PMID:
29217828
5.

Ectodermal dysplasia with immunodeficiency caused by a branch-point mutation in IKBKG/NEMO.

Jørgensen SE, Bøttger P, Kofod-Olsen E, Holm M, Mørk N, Ørntoft TF, Sørensen UBS, Bernth-Jensen JM, Herlin T, Veirum J, Larsen CS, Østergaard L, Hartmann R, Christiansen M, Mogensen TH.

J Allergy Clin Immunol. 2016 Dec;138(6):1706-1709.e4. doi: 10.1016/j.jaci.2016.05.030. Epub 2016 Jun 29. No abstract available.

PMID:
27477329
6.

Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis.

Mørk N, Kofod-Olsen E, Sørensen KB, Bach E, Ørntoft TF, Østergaard L, Paludan SR, Christiansen M, Mogensen TH.

Genes Immun. 2015 Dec;16(8):552-66. doi: 10.1038/gene.2015.46. Epub 2015 Oct 29.

PMID:
26513235
7.

Functional IRF3 deficiency in a patient with herpes simplex encephalitis.

Andersen LL, Mørk N, Reinert LS, Kofod-Olsen E, Narita R, Jørgensen SE, Skipper KA, Höning K, Gad HH, Østergaard L, Ørntoft TF, Hornung V, Paludan SR, Mikkelsen JG, Fujita T, Christiansen M, Hartmann R, Mogensen TH.

J Exp Med. 2015 Aug 24;212(9):1371-9. doi: 10.1084/jem.20142274. Epub 2015 Jul 27.

8.

Perceived safety and benefit of community water fluoridation: 2009 HealthStyles survey.

Mork N, Griffin S.

J Public Health Dent. 2015 Fall;75(4):327-36. doi: 10.1111/jphd.12104. Epub 2015 Jul 3.

9.

[A boy with a wound on his finger that would not heal].

Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS.

Tidsskr Nor Laegeforen. 2015 Mar 10;135(5):445-8. doi: 10.4045/tidsskr.14.0759. eCollection 2015 Mar 10. Norwegian. No abstract available.

10.

Implementing best practice in psoriasis: a Nordic expert group consensus.

Kragballe K, Gniadecki R, Mørk NJ, Rantanen T, Ståhle M.

Acta Derm Venereol. 2014 Sep;94(5):547-52. doi: 10.2340/00015555-1809.

11.

[A horseshoe-shaped wound on the back].

Rizvi SM, Mørk NJ, Gjersvik P.

Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):2270. doi: 10.4045/tidsskr.13.0808. Norwegian. No abstract available.

12.

[Syed Mohammad Husain Rizvi and colleagues reply].

Rizvi SM, Kvernebo MS, Mørk NJ, Gjersvik P.

Tidsskr Nor Laegeforen. 2013 May 28;133(10):1047. doi: 10.4045/tidsskr.13.0621. Norwegian. No abstract available.

13.

[Young boy with fever, sore throat, sore lips and bullous rashes].

Rizvi SM, Kvernebo MS, Mørk NJ, Gjersvik P.

Tidsskr Nor Laegeforen. 2013 Mar 19;133(6):646-8. doi: 10.4045/tidsskr.12.0939. Norwegian. No abstract available.

14.

Initial adhesion of Listeria monocytogenes to solid surfaces under liquid flow.

Szlavik J, Paiva DS, Mørk N, van den Berg F, Verran J, Whitehead K, Knøchel S, Nielsen DS.

Int J Food Microbiol. 2012 Jan 16;152(3):181-8. doi: 10.1016/j.ijfoodmicro.2011.09.006. Epub 2011 Sep 14.

PMID:
21968113
15.

[A man with erythrodermia, muscle weakness and weight loss].

Gran JT, Gunnarsson R, Mørk NJ.

Tidsskr Nor Laegeforen. 2009 Nov 5;129(21):2240-1. doi: 10.4045/tidsskr.09.0184. Norwegian.

16.

The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.

Zachariae C, Mørk NJ, Reunala T, Lorentzen H, Falk E, Karvonen SL, Johannesson A, Claréus B, Skov L, Mørk G, Walker S, Qvitzau S.

Acta Derm Venereol. 2008;88(5):495-501. doi: 10.2340/00015555-0511.

17.

Bamboo spine mimicking Bekhterev's disease caused by long-term acitretin treatment.

Mørk NJ, Austad J, Kolbenstvedt A.

Acta Derm Venereol. 2006;86(5):452-3. No abstract available.

18.

The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.

de Jong EM, Mørk NJ, Seijger MM, De La Brassine M, Lauharanta J, Jansen CT, Guilhou JJ, Guillot B, Ostrojic A, Souteyrand P, Vaillant L, Barnes L, Rogers S, Klaber MR, Van De Kerkhof PC.

Br J Dermatol. 2003 Feb;148(2):318-25.

PMID:
12588386
19.

Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression.

Virtanen M, Gedde-Dahl T Jr, Mörk NJ, Leigh I, Bowden PE, Vahlquist A.

Acta Derm Venereol. 2001 Jun-Jul;81(3):163-70.

20.

[Pathological findings in the eye of children with facial nevus].

Helsing P, Mørk NJ, Flage T.

Tidsskr Nor Laegeforen. 2001 Jun 20;121(16):1911-2. Norwegian.

21.

[Pyoderma gangrenosum--possible diagnosis in therapy-resistant wounds].

Mørk G, Mørk NJ.

Tidsskr Nor Laegeforen. 2000 Oct 30;120(26):3156-8. Norwegian.

22.

Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.

Ho VC, Griffiths CE, Albrecht G, Vanaclocha F, León-Dorantes G, Atakan N, Reitamo S, Ohannesson A, Mørk NJ, Clarke P, Pfister P, Paul C.

Br J Dermatol. 1999 Aug;141(2):283-91.

PMID:
10468801
23.

Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.

Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.

J Eur Acad Dermatol Venereol. 1998 Jul;11(1):19-24.

PMID:
9731961
24.

Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.

Zachariae H, Abrams B, Bleehen SS, Bräutigam M, Burrows D, Ettelt MJ, Fry L, Happle R, Haustein UF, Ganslandt J, Jung EG, Knop J, Kühne KH, Mellein B, Mørk NJ, Rogers S, Schmidt AG, Schopf RE, Sumner M, Taube KM, Weidinger G, Wurdel C, Zahn E.

Dermatology. 1998;196(2):231-6.

PMID:
9568413
25.

[Dermatologic laser therapy].

Mørk NJ.

Tidsskr Nor Laegeforen. 1997 Aug 30;117(20):2988. Norwegian. No abstract available.

PMID:
9395432
27.

[Nevus flammeus in small children treated pulsed dye laser].

Mørk NJ, Austad J, Helsing P, Kasbohm E.

Tidsskr Nor Laegeforen. 1996 Nov 30;116(29):3474-5. Norwegian.

PMID:
9019852
28.

Skeletal side-effects of 5 years' acitretin treatment.

Mørk NJ, Kolbenstvedt A, Austad J.

Br J Dermatol. 1996 Jun;134(6):1156-7. No abstract available.

PMID:
8763451
29.

Efficacy and skeletal side effects of two years' acitretin treatment.

Mørk NJ, Kolbenstvedt A, Austad J.

Acta Derm Venereol. 1992 Nov;72(6):445-8.

PMID:
1362840
31.
32.
33.

[Dermatological laser treatment].

Mørk NJ, Austad J, Helland S, Thune P, Volden G, Falk E.

Tidsskr Nor Laegeforen. 1991 Oct 10;111(24):2960-2. Norwegian.

PMID:
1948901
34.

Kinetics of hydrolysis of indomethacin and indomethacin ester prodrugs in aqueous solution.

Kahns AH, Jensen PB, Mørk N, Bundgaard H.

Acta Pharm Nord. 1989;1(6):327-36.

PMID:
2624703
35.

A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.

Kragballe K, Jansén CT, Geiger JM, Bjerke JR, Falk ES, Gip L, Hjorth N, Lauharanta J, Mork NJ, Reunala T, et al.

Acta Derm Venereol. 1989;69(1):35-40.

PMID:
2563606
36.

UVC irradiation of human epidermal Langerhans cells decreases the alloactivating and antigen presenting capacity.

Mørk NJ, Børufsen H, Braathen LR.

Clin Exp Dermatol. 1988 Nov;13(6):371-5. No abstract available.

PMID:
3267179
37.

[Photochemotherapy and skin cancer. The occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy)].

Mørk NJ, Braathen LR, Rajka G, Hoel PS.

Tidsskr Nor Laegeforen. 1988 Mar 20;108(8-9):676-8. Norwegian. No abstract available.

PMID:
3353970
38.

[Argon laser treatment of capillary hemangioma (nevus flammeus)].

Mørk NJ, Austad J.

Tidsskr Nor Laegeforen. 1987 Aug 20;107(23):1896-7. Norwegian. No abstract available.

PMID:
3660375
39.

[Chronic erythema migrans and chronic acrodermatitis atrophicans. Tick-borne Borrelia spirochete infections of the skin].

Braathen LR, Austad J, Mørk NJ, Holm JO, Mehl R.

Tidsskr Nor Laegeforen. 1987 Jun 30;107(19-21):1649-51. Norwegian. No abstract available.

PMID:
3629569
40.

Effect of UVA and PUVA on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells.

Mørk NJ, Gaudernack G, Braathen LR.

Photodermatol. 1987 Apr;4(2):66-72.

PMID:
3498937
41.

Vulval lichen sclerosus et atrophicus treated with etretinate (Tigason).

Mørk NJ, Jensen P, Hoel PS.

Acta Derm Venereol. 1986;66(4):363-5.

PMID:
2430416
42.
43.

[Hyalinosis cutis et mucosae. Lipoid proteinosis, Urbach-Wiethe disease].

Jensen P, Mørk NJ, Hoel PS, Jellum E.

Tidsskr Nor Laegeforen. 1985 Feb 28;105(6):428-30. Norwegian. No abstract available.

PMID:
3983944
44.

[Isotretinoin (Roaccutan). A new drug against severe acne].

Austad J, Mørk NJ.

Tidsskr Nor Laegeforen. 1984 Aug 30;104(24):1639-41. Norwegian. No abstract available.

PMID:
6236579
45.

[Climate therapy of psoriasis patients].

Austad J, Mørk NJ.

Tidsskr Nor Laegeforen. 1984 Aug 20;104(23):1548-9. Norwegian. No abstract available.

PMID:
6484912
46.

Contact dermatitis from witisol, a sunscreen agent.

Mørk NJ, Austad J.

Contact Dermatitis. 1984 Feb;10(2):122-3. No abstract available.

PMID:
6713838
47.

[Dermatologic complications of immunosuppressive treatment. Illustrated by 2 cases].

Mørk NJ, Gabrielsen TO.

Tidsskr Nor Laegeforen. 1984 Jan 30;104(3):162-3. Norwegian. No abstract available.

PMID:
6701852
49.

Coexistence of discoid lupus erythematosus and dermatitis herpetiformis.

Mørk NJ, Kramer M.

Dermatologica. 1983;166(2):110. No abstract available.

PMID:
6852315
50.

Short-wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands.

Mørk NJ, Austad J.

Acta Derm Venereol. 1983;63(1):87-9.

PMID:
6191504

Supplemental Content

Support Center